Daily closing price · 250 sessions
Quantitative price outlook based on available market signals. Not financial advice.
Indicators calculated from the stored daily price history.
A verified, data-driven analysis will be generated here from price action, technical indicators, fundamentals, earnings and market context.
Dedicated research sections for 2026, 2030, 2035, 2040 and 2050. Numerical targets will appear only after the long-horizon model is validated.
Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2026 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2030 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2035 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2040 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2050 research →Historical outcomes are shown only after a prediction has matured and been evaluated.
Absolute percentage error: 1.81%
Absolute percentage error: 3.32%
Only stories explicitly associated with this stock are shown.
An experienced analyst shares a seven-step stock research methodology developed over years of analyzing hundreds of companies. The process includes comparing returns to the S&P 500, analyzing financial reports, mapping business models, evaluating competitive advantages, assessing macro trends, reviewing leadership, conducting risk analysis, and determining valuation. The author uses Apple and Costco as examples of companies that meet their investment criteria.
The article recommends five resilient stocks suitable for uncertain market conditions: Johnson & Johnson (pharmaceutical and medtech leader with 28 billion-dollar products), Vertex Pharmaceuticals (cystic fibrosis treatment market leader with pipeline expansion), Costco (essential goods retailer with high membership renewal rates), Coca-Cola (beverage company with strong brands and free cash flow), and American Express (payment card company with affluent customer base). These companies offer stability through essential products, strong market positions, and consistent dividend payments.
Walmart beat Q2 earnings expectations with 5.9% revenue growth and 19.1% EPS increase to 81 cents, while raising fiscal 2027 guidance. However, rising healthcare, fuel, and depreciation costs, combined with increased capital expenditures (4% of sales vs. 3.5% prior guidance), may limit near-term profit growth and cash conversion despite strong digital momentum.
Target Corporation reported strong second-quarter fiscal 2026 results, with stores fulfilling 97.6% of merchandise sales and serving as core omnichannel hubs. Comparable digital sales rose 8.7%, same-day delivery grew over 25%, and the company opened 17 new stores in Q2. Target's shares have rallied 17% over three months, outperforming competitors, and the stock carries a Zacks Rank #2 (Buy) rating with improved earnings estimates.
Walmart reported strong Q2 fiscal 2027 results with U.S. e-commerce sales rising 24% and store-fulfilled delivery sales growing 43%. The company's fast-delivery service expanded to 38 markets with sub-30-minute delivery options, with stores fulfilling 80% of e-commerce orders. Fast-delivery customers show higher engagement and are more likely to become Walmart+ members. Walmart is also expanding delivery partnerships, including a collaboration with Dunkin'.
Common questions about price, predictions, long-term forecasts, technicals and research methodology.
COST is currently shown at $893.74 in the latest stored market quote. The page is refreshed from the connected market-data pipeline.
US Market AI currently shows quantitative forecasts for 24H, 7D, 30D and 90D using the stored market signals. The forecasts are estimates and not guarantees.
The 2026 long-term forecast section is included as a research framework. A numerical 2026 target is shown only after a dedicated long-horizon model has produced and validated it; the current 24H–90D model is not presented as a 2026 target.
The 2030 section tracks the inputs that a validated long-horizon model should use, including company growth, valuation, earnings, market regime and sector conditions. No unsupported price target is displayed.
The 2035, 2040 and 2050 sections are reserved for long-term model outputs. US Market AI does not invent numerical targets when validated long-horizon data is unavailable.
The page can display RSI, MACD, SMA 50, SMA 200, EMA 20, ATR, ADX, volatility, Bollinger levels, stochastic, support and resistance from stored daily price history.
Fundamental data is not currently populated for this stock, so the page does not estimate or fabricate missing values.
The latest ticker-linked news appears in the Market News section of this page. Stories are shown with source, publication date and sentiment when available.
Only predictions that have matured are evaluated. Recent evaluated outcomes are shown in the model-validation section; accuracy should be interpreted using the full mature sample rather than a single result.
No. US Market AI provides research and model estimates for informational purposes. Forecasts can be wrong and should not be treated as personalized financial advice.
Explore other active stocks in the same sector.
US Market AI combines quantitative signals and verified market data to support research. Forecasts are estimates, can be wrong, and are not financial advice.